MIR22HG and osteosarcoma: Specifically, overexpressed MIR22HG is an lncRNA low-expressed in osteosarcoma, which is associated with the suppressed viability and proliferation and the promoted apoptosis of osteosarcoma cells, the effects of which are associated with the regulation on miR-629-5p/TET3 axis.